(S)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide,
darifenacin,
darifenacin hydrobromide,
darifenacin hydrochloride,
darifenacine,
darifenicin,
Emselex,
Enablex,
UK-88525,
Darifenacin hydrobromide,
darifenacin HBr,
133099-07-7,
Darifenacin (hydrobromide),
Emselex,
UNII-CR02EYQ8GV,
UK 88525-04 hydrobromide,
CR02EYQ8GV,
CHEBI:31455,
UK-88525-04,
DSSTox_CID_26780,
DSSTox_RID_81899,
DSSTox_GSID_46780,
(S)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide hydrobromide,
(S)-2-{1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide,
UK-88525,
Q-101006,
Darilong,
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide,
3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (3S)-,
3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (S)-,
3-PYRROLIDINEACETAMIDE, 1-[2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL]-ALPHA,ALPHA-DIPHENYL-, HYDROBROMIDE (1:1), (3S)-,
CAS-133099-07-7,
NCGC00168775-01,
Darifenacin hydrobromide [USAN],
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide,
Enablex (TN),
darifenacin-hydrobromide,
PubChem14816,
AC1L9FKV,
ENABLEX HYDROBROMIDE,
CHEMBL1200935,
DTXSID9046780,
KS-00000KBH,
UQAVIASOPREUIT-VQIWEWKSSA-N,
HY-A0012,
Tox21_112636,
Darifenacin hydrobromide (JAN/USAN),
MFCD08141803,
s3144,
AKOS015969311,
Tox21_112636_1,
AC-1894,
AN-6905,
API0008085,
CCG-220969,
CS-0380,
MCULE-9754914075,
SB17426,
NCGC00263922-02,
UK-88525-04 (HYDROBROMIDE),
AS-35087,
BC003938,
BC201082,
Darifenacin hydrobromide, >=98% (HPLC),
AB0073012,
LS-186532,
SW219426-1,
D01699,
W-5366,
Z1691545283,
Darifenacin hydrobromide, United States Pharmacopeia (USP) Reference Standard,
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-|A-|A-diphenyl-3-pyrrolidineacetamide Hydrobromide,
[1-[2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL]-3-PYRROLIDNYL]-2,2-DIPHENYLACETAMIDE HYDROBROMIDE,
2-[(3S)-1-[2-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)ETHYL]-3-PYRROLIDINYL]-2,2-DIPHENYLACETAMIDE HYDROBROMIDE,
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide,
2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide hydrobromide,
Enablex,
Darifenacin Hydrobrimide,
C28H30N2O2.BrH,
C28-H30-N2-O2.Br-H,
CID444030,
CS-O-01267,
B1600,
Darifenacin hydrobromide, 98% - 250MG 250mg,
{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide,